ArticleJournal of translational medicine2023

Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.

Benito Farina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.